These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 26932318)

  • 1. Untargeted plasma and tissue metabolomics in rats with chronic kidney disease given AST-120.
    Velenosi TJ; Hennop A; Feere DA; Tieu A; Kucey AS; Kyriacou P; McCuaig LE; Nevison SE; Kerr MA; Urquhart BL
    Sci Rep; 2016 Mar; 6():22526. PubMed ID: 26932318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolomic search for uremic toxins as indicators of the effect of an oral sorbent AST-120 by liquid chromatography/tandem mass spectrometry.
    Kikuchi K; Itoh Y; Tateoka R; Ezawa A; Murakami K; Niwa T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Nov; 878(29):2997-3002. PubMed ID: 20870466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the Oral Adsorbent AST-120 on Organ-Specific Accumulation of Uremic Toxins: LC-MS/MS and MS Imaging Techniques.
    Sato E; Saigusa D; Mishima E; Uchida T; Miura D; Morikawa-Ichinose T; Kisu K; Sekimoto A; Saito R; Oe Y; Matsumoto Y; Tomioka Y; Mori T; Takahashi N; Sato H; Abe T; Niwa T; Ito S
    Toxins (Basel); 2017 Dec; 10(1):. PubMed ID: 29283413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut microbiota generation of protein-bound uremic toxins and related metabolites is not altered at different stages of chronic kidney disease.
    Gryp T; De Paepe K; Vanholder R; Kerckhof FM; Van Biesen W; Van de Wiele T; Verbeke F; Speeckaert M; Joossens M; Couttenye MM; Vaneechoutte M; Glorieux G
    Kidney Int; 2020 Jun; 97(6):1230-1242. PubMed ID: 32317112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the impact of gut microbiota on uremic solute accumulation by a CE-TOFMS-based metabolomics approach.
    Mishima E; Fukuda S; Mukawa C; Yuri A; Kanemitsu Y; Matsumoto Y; Akiyama Y; Fukuda NN; Tsukamoto H; Asaji K; Shima H; Kikuchi K; Suzuki C; Suzuki T; Tomioka Y; Soga T; Ito S; Abe T
    Kidney Int; 2017 Sep; 92(3):634-645. PubMed ID: 28396122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The protein metabolite hypothesis, a model for the progression of renal failure: an oral adsorbent lowers indoxyl sulfate levels in undialyzed uremic patients.
    Niwa T; Nomura T; Sugiyama S; Miyazaki T; Tsukushi S; Tsutsui S
    Kidney Int Suppl; 1997 Nov; 62():S23-8. PubMed ID: 9350673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the oral adsorbent AST-120 on fecal p-cresol and indole levels and on the gut microbiota composition.
    Sato E; Hosomi K; Sekimoto A; Mishima E; Oe Y; Saigusa D; Ito S; Abe T; Sato H; Kunisawa J; Niwa T; Takahashi N
    Biochem Biophys Res Commun; 2020 May; 525(3):773-779. PubMed ID: 32147096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An oral adsorbent, AST-120, suppresses oxidative stress in uremic rats.
    Nakagawa N; Hasebe N; Sumitomo K; Fujino T; Fukuzawa J; Hirayama T; Kikuchi K
    Am J Nephrol; 2006; 26(5):455-61. PubMed ID: 17057375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of oral adsorbent on gene expression profile in uremic rat kidney: cDNA array analysis.
    Aoyama I; Enomoto A; Niwa T
    Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S8-14. PubMed ID: 12612943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of AST-120 on blood concentrations of protein-bound uremic toxins and biomarkers of cardiovascular risk in chronic dialysis patients.
    Lee CT; Hsu CY; Tain YL; Ng HY; Cheng BC; Yang CC; Wu CH; Chiou TT; Lee YT; Liao SC
    Blood Purif; 2014; 37(1):76-83. PubMed ID: 24576840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deleterious vascular effects of indoxyl sulfate and reversal by oral adsorbent AST-120.
    Six I; Gross P; Rémond MC; Chillon JM; Poirot S; Drueke TB; Massy ZA
    Atherosclerosis; 2015 Nov; 243(1):248-56. PubMed ID: 26408929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of carbon adsorbent in the conservative management of chronic kidney disease.
    Niwa T
    Panminerva Med; 2017 Jun; 59(2):139-148. PubMed ID: 27990791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral Charcoal Adsorbents Attenuate Neointima Formation of Arteriovenous Fistulas.
    Shih YC; Wu CC; Wang SC; Liou JY; Huang PH; Tarng DC
    Toxins (Basel); 2020 Apr; 12(4):. PubMed ID: 32276394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A metabolomic approach to clarifying the effect of AST-120 on 5/6 nephrectomized rats by capillary electrophoresis with mass spectrometry (CE-MS).
    Akiyama Y; Takeuchi Y; Kikuchi K; Mishima E; Yamamoto Y; Suzuki C; Toyohara T; Suzuki T; Hozawa A; Ito S; Soga T; Abe T
    Toxins (Basel); 2012 Nov; 4(11):1309-22. PubMed ID: 23202318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indoxyl sulfate down-regulates SLCO4C1 transporter through up-regulation of GATA3.
    Akiyama Y; Kikuchi K; Saigusa D; Suzuki T; Takeuchi Y; Mishima E; Yamamoto Y; Ishida A; Sugawara D; Jinno D; Shima H; Toyohara T; Suzuki C; Souma T; Moriguchi T; Tomioka Y; Ito S; Abe T
    PLoS One; 2013; 8(7):e66518. PubMed ID: 23874392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of oral adsorbent AST-120 under standard treatment of care in patients with chronic renal failure].
    Yoshida I; Komada T; Sakuma Y; Mori H; Funayama I; Tabei K
    Nihon Jinzo Gakkai Shi; 2009; 51(2):121-9. PubMed ID: 19378798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the oral adsorbent AST-120 on tryptophan metabolism in uremic patients.
    Tsubakihara Y; Takabatake Y; Oka K; Shoji T; Togawa M; Okada N; Takahito I; Imai E
    Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S38-41. PubMed ID: 12612950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Uremic Toxins from the Gut Microbiota on Bone: A Brief Look at Chronic Kidney Disease.
    Black AP; Cardozo LF; Mafra D
    Ther Apher Dial; 2015 Oct; 19(5):436-40. PubMed ID: 25944654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploration of novel predictive markers in rat plasma of the early stages of chronic renal failure.
    Kobayashi T; Matsumura Y; Ozawa T; Yanai H; Iwasawa A; Kamachi T; Fujiwara K; Tanaka N; Kohno M
    Anal Bioanal Chem; 2014 Feb; 406(5):1365-76. PubMed ID: 24232639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of uremic toxins in advanced chronic kidney disease patients on maintenance hemodialysis by LC-ESI-MS/MS.
    Ragi N; Pallerla P; Babi Reddy Gari AR; Lingampelly SS; Ketavarapu V; Addipilli R; Chirra N; Kantevari S; Yadla M; Sripadi P
    Metabolomics; 2023 Feb; 19(3):14. PubMed ID: 36826619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.